Rise Advisors’s Repligen RGEN Stock Holding History

Rise Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-123	Closed	-$16.4K	–	1140
2025 Q3	$16.4K	Sell	123 -4	-3%	-$486	0.01%	699
2025 Q2	$15.8K	Buy	127 +1	+0.8%	+$127	0.01%	682
2025 Q1	$16K	Buy	+126	New	+$19.4K	0.01%	645
2024 Q4	–	Sell	-49	Closed	-$7.29K	–	1193
2024 Q3	$7.29K	Sell	49 -48	-49%	-$6.88K	﹤0.01%	1054
2024 Q2	$12.2K	Sell	97 -2	-2%	-$313	0.01%	929
2024 Q1	$18.2K	Sell	99 -24	-20%	-$4.57K	0.01%	708
2023 Q4	$22.1K	Hold	123	–	–	0.02%	244
2023 Q3	$19.6K	Sell	123 -27	-18%	-$4.41K	0.02%	241
2023 Q2	$21.2K	Sell	150 -42	-22%	-$6.74K	0.02%	230
2023 Q1	$32.3K	Hold	192	–	–	0.02%	196
2022 Q4	$32.5K	Hold	192	–	–	0.03%	192
2022 Q3	$36K	Sell	192 -3	-2%	-$633	0.03%	185
2022 Q2	$32K	Hold	195	–	–	0.03%	187
2022 Q1	$37K	Hold	195	–	–	0.03%	180
2021 Q4	$51.6K	Buy	+195	New	+$52.5K	0.05%	144

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Rise Advisors's RGEN Position: Q4 2025 in Review

Rise Advisors sold out of Repligen (RGEN) in Q4 2025, closing a stake of 123 shares — an estimated $16.4K sold.

Rise Advisors first reported a position in RGEN in Q4 2021 and held it in 15 quarters. The position peaked at $51.6K in Q4 2021. 474 funds tracked by Wall St. Rank hold RGEN as of Q4 2025.

Rise Advisors reported no remaining Repligen position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 123 Repligen shares in Q4 2025, an estimated $16.4K.
Rise Advisors first reported a position in Repligen in Q4 2021 and held it in 15 quarters.
Rise Advisors's Repligen position peaked at $51.6K in Q4 2021.
474 funds tracked by Wall St. Rank held Repligen as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.